Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

INDP

Indaptus Therapeutics, Inc.

CIK 0001857044 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$2.50
↑ 0.05 (2.04%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Fundamentals, Technicals; Excluded: Options (no data)

Key stats

Market Cap
$283.11M
P/E Ratio
-15.01
EPS
-21.58
Dividend Yield
Not covered
52W Position
13%
Beta
2.74

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
226.87
P/S
Not covered
EV/Revenue
Not covered
ROE
-1511.2%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 13%
$0.92$13.40

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$20.85M
Total Assets
$9.31M
Free Cash Flow
–

Recent news